Update on the pathogenesis and management of pneumonia in the elderly-roles of aspiration pneumonia

Respiratory Investigation

Volumn 53, Issue 5, 2015, Pages 178-184

  Teramoto, Shinji ^a   Yoshida, Kazufumi ^b   Hizawa, Nobuyuki ^c  

^a UNIVERSITY OF TSUKUBA HOSPITAL   (Japan)

^b HITACHI LTD   (Japan)

^c UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

Aspiration pneumonia; Dysphagia; Oral health care; Pneumococcal vaccination; Swallowing rehabilitation

Indexed keywords

ANTIBIOTIC AGENT; CILOSTAZOL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; INFLUENZA VACCINE; PNEUMOCOCCUS VACCINE; ANTIINFECTIVE AGENT;

ASPIRATION PNEUMONIA; BACTERIAL PNEUMONIA; BACTERIUM IDENTIFICATION; CLINICAL ASSESSMENT; CLINICAL FEATURE; DRUG CHOICE; DYSPHAGIA; GERIATRIC CARE; HUMAN; MOUTH HYGIENE; NONHUMAN; PATHOGENESIS; PHARMACEUTICAL CARE; PNEUMONIA; REHABILITATION CARE; REVIEW; SYMPTOM ASSESSMENT; TREATMENT PLANNING; UPPER RESPIRATORY TRACT; BODY POSTURE; COMPLICATION; DEGLUTITION DISORDERS; DIFFERENTIAL DIAGNOSIS; GASTROESOPHAGEAL REFLUX; MALE; MICROBIOLOGY; PATHOPHYSIOLOGY; RECURRENT DISEASE; RESPIRATION CONTROL; RESPIRATORY TRACT INFECTION; SWALLOWING;

AIRWAY MANAGEMENT; ANTI-BACTERIAL AGENTS; DEGLUTITION; DEGLUTITION DISORDERS; DIAGNOSIS, DIFFERENTIAL; GASTROESOPHAGEAL REFLUX; HUMANS; MALE; PNEUMOCOCCAL VACCINES; POSTURE; RECURRENCE; RESPIRATORY TRACT INFECTIONS;

EID: 84940824882     PISSN: 22125345     EISSN: 22125353     Source Type: Journal    
DOI: 10.1016/j.resinv.2015.01.003     Document Type: Review

References (67)

1. Mandell LA, Wunderink R.G., Anzueto A., et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 2007, 44(Suppl. 2):S27-S72.
2. Ochoa-Gondar O., Vila-Córcoles A., de Diego C., et al. The burden of community-acquired pneumonia in the elderly: the Spanish EVAN-65 study. BMC Public Health 2008, 8:222.
3. Teramoto S., Yamamoto H., Yamaguchi Y., et al. Lower respiratory tract infection outcomes are predicted better by an age>80 years than by CURB-65. Eur Respir J 2008, 31:477-478.
4. American Thoracic Society and the Infectious Diseases Society of America: guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005, 171:388-416.
5. The committee for the Japanese Respiratory Society guidelines in management of respiratory infections The Japanese Respiratory Society guideline for the management of community-acquired pneumonia in adults. Respirology 2006, 11:S1-S133.
6. Kohno S., Imamura Y., Shindo Y., et al. Clinical practice guidelines for nursing- and healthcare-associated pneumonia (NHCAP) [complete translation]. Respir Investig 2013, 51:103-126.
7. Teramoto S., Fukuchi Y., Sasaki H., et al. High incidence of aspiration pneumonia in community- and hospital-acquired pneumonia in hospitalized patients: a multicenter, prospective study in Japan. J Am Geriatr Soc 2008, 56:577-579.
8. The committee for the Japanese Respiratory Society guidelines in management of respiratory infections The Japanese Respiratory Society guideline for the management of hospital-acquired pneumonia in adults. Respirology 2009, 14:S1-S71.
9. Kikuchi R., Watabe N., Konno T., et al. High incidence of silent aspiration in elderly patients with community-acquired pneumonia. Am J Respir Crit Care Med 1994, 150:251-253.
10. Teramoto S. Novel preventive and therapuetic strategy for post-stroke pneumonia. Expert Rev Neurother 2009, 9:1187-1200.
11. Shimada M., Teramoto S., Matsui H., et al. Nine pulmonary aspiration syndrome cases of atypical clinical presentation, in which the final diagnosis was obtained by histological examinations. Respir Investig 2014, 52:14-20.
12. Teramoto S., Kawashima M., Komiya K., et al. Health-care-associated pneumonia is primarily due to aspiration pneumonia. Chest 2009, 136:1702-1703.
13. Osawa A., Maeshima S., Tanahashi N. Water-swallowing test: screening for aspiration in stroke patients. Cerebrovasc Dis 2013, 35:276-281.
14. Teramoto S., Yamamoto H., Yamaguchi Y., et al. A novel diagnostic test for the risk of aspiration pneumonia in the elderly. Chest 2004, 125:801-802.
15. Teramoto S., Matsuse T., Fukuchi Y., et al. Simple two-step swallowing provocation test for elderly patients with aspiration pneumonia. Lancet 1999, 353:1243.
16. Marrie T.J. Community-acquired pneumonia in the elderly. Clin Infect Dis 2000, 31:1066-1078.
17. Riquelme R., Torres A., Wl-Ebiary M., et al. Community-acquired pneumonia in the elderly. Am J Respir Crit Care Med 1997, 156:1908-1914.
18. Matsuo T., Ishikawa H., Tachi H., et al. Development of exudative tuberculosis during treatment for aspiration pneumonia in an elderly post-stroke patient with symptomatic epilepsy. Nihon Ronen Igakkai Zasshi 2014, 51:460-465. [in Japanese].
19. Lorber B., Swenson R.M. Bacteriology of aspiration pneumonia. A prospective study of community- and hospital-acquired cases. Ann Intern Med 1974, 81:329-331.
20. Bartlett J.G., Gorbach S.L. The triple threat of aspiration pneumonia. Chest 1975, 68:560-566.
21. Micek S.T., Kollef K.E., Reichley R.M., et al. Health care-associated pneumonia and community-acquired pneumonia: a single-center experience. Antimicrob Agents Chemother 2007, 51:3568-3573.
22. Carratalà J., Mykietiuk A., Fernández-Sabé N., et al. Health care-associated pneumonia requiring hospital admission: epidemiology, antibiotic therapy, and clinical outcomes. Arch Intern Med 2007, 167:1393-1399.
23. Maruyama T., Gabazza E.C., Morser J., et al. Community-acquired pneumonia and nursing home-acquired pneumonia in the very elderly patients. Respir Med 2010, 104:584-592.
24. Ishida T., Tachibana H., Ito A., et al. Clinical characteristics of nursing and healthcare-associated pneumonia: a Japanese variant of healthcare-associated pneumonia. Intern Med 2012, 51:2537-2544.
25. Miyashita N., Kawai Y., Akaike H., et al. Clinical features and the role of atypical pathogens in nursing and healthcare-associated pneumonia (NHCAP): differences between a teaching university hospital and a community hospital. Intern Med 2012, 51:585-594.
26. Polverino E., Torres A., Menendez R., et al. Microbial aetiology of healthcare associated pneumonia in Spain: a prospective, multicentre, case-control study. Thorax 2013, 68:1007-1014.
27. Fukuyama H., Yamashiro S., Tamaki H., et al. A prospective comparison of nursing- and healthcare-associated pneumonia (NHCAP) with community-acquired pneumonia (CAP). J Infect Chemother 2013, 19:719-726.
28. Chalmers J.D., Taylor J.K., Singanayagam A., et al. Epidemiology, antibiotic therapy, and clinical outcomes in health care-associated pneumonia: a UK cohort study. Clin Infect Dis 2011, 53:107-113.
29. Yamasaki K., Kawanami T., Yatera K., et al. Significance of anaerobes and oral bacteria in community-acquired pneumonia. PLoS One 2013, 8:e63103.
30. Allewelt M., Schuler P., Bolcskei P.L., et al. Ampicillin+sulbactam vs clindamycin±cephalosporin for the treatment of aspiration pneumonia and primary lung abscess. Clin Microbiol Infect 2004, 10:163-170.
31. Kohno S., Yanagihara K., Yamamoto Y., et al. Early switch therapy from intravenous sulbactam/ampicillin to oral garenoxacin in patients with community-acquired pneumonia: a multicenter, randomized study in Japan. J Infect Chemother 2013, 19:1035-1041.
32. Ito I., Kadowaki S., Tanabe N., et al. Tazobactam/piperacillin for moderate-to-severe pneumonia in patients with risk for aspiration: comparison with imipenem/cilastatin. Pulm Pharmacol Ther 2010, 23:403-410.
33. Karino F., Miura K., Fuchita H., et al. Efficacy and safety of piperacillin/tazobactam versus biapenem in late elderly patients with nursing- and healthcare-associated pneumonia. J Infect Chemother 2013, 19:909-915.
34. Mortensen E.M., Halm E.A., Pugh M.J., et al. Association of azithromycin with mortality and cardiovascular events among older patients hospitalized with pneumonia. J Am Med Assoc 2014, 311:2199-2208.
35. Marumo S., Teranishi T., Higami Y., et al. Effectiveness of azithromycin in aspiration pneumonia: a prospective observational study. BMC Infect Dis 2014, 14:685. [Epub ahead of print].
36. Lin C.W., Chang Y.C., Chen W.S., et al. Prolonged swallowing time in dysphagic Parkinsonism patients with aspiration pneumonia. Arch Phys Med Rehabil 2012, 93:2080-2084.
37. Kaizer F., Spiridigliozzi A.M., Hunt M.R. Promoting shared decision-making in rehabilitation: development of a framework for situations when patients with Dysphagia refuse diet modification recommended by the treating team. Dysphagia 2012, 27:81-87.
38. Iwamoto M., Higashibeppu N., Arioka Y., et al. Swallowing rehabilitation with nutrition therapy improves clinical outcome in patients with dysphagia at an acute care hospital. J Med Invest 2014, 61:353-360.
39. El-Rabbany M., Zaghlol N., Bhandari M., et al. Prophylactic oral health procedures to prevent hospital-acquired and ventilator-associated pneumonia: a systematic review. Int J Nurs Stud 2015, 52:452-464.
40. Maeda K., Akagi J. Oral care may reduce pneumonia in the tube-fed elderly: a preliminary study. Dysphagia 2014, 29:616-621.
41. Yoneyama T., Yoshida M., Matsui T., et al. Oral care and pneumonia. Oral Care Working Group. Lancet 1999, 354:515.
42. Matsusaka K., Ohi A., Tahata K., et al. Addition of oral cavity brushing and rehabilitation reduces fever in tube-fed patients. Geriatr Gerontol Int 2013, 13:1082-1084.
43. Bassim C.W., Gibson G., Ward T., et al. Modification of the risk of mortality from pneumonia with oral hygiene care. J Am Geriatr Soc 2008, 56:1601-1607.
44. Momosaki R, Yasunaga H, Matsui H, et al. Effect of early rehabilitation by physical therapists on in-hospital mortality after aspiration pneumonia in the elderly. Arch Phys Med Rehabil 2015, 96:205-209.
45. Gomes C.A., Lustosa S.A., Matos D., et al. Percutaneous endoscopic gastrostomy versus nasogastric tube feeding for adults with swallowing disturbances. Cochrane Database Syst Rev 2010, 15:CD008096.
46. Matsui T., Yamaya M., Ohrui T., et al. Sitting position to prevent aspiration in bed-bound patients. Gerontology 2002, 48:194-195.
47. Satou Y., Oguro H., Murakami Y., et al. Gastroesophageal reflux during enteral feeding in stroke patients: a 24-hour esophageal pH-monitoring study. J Stroke Cerebrovasc Dis 2013, 22:185-189.
48. He M., Ohrui T., Ebihara T., et al. Mosapride citrate prolongs survival in stroke patients with gastrostomy. J Am Geriatr Soc 2007, 55:142-144.
49. Takatori K., Yoshida R., Horai A., et al. Therapeutic effects of mosapride citrate and lansoprazole for prevention of aspiration pneumonia in patients receiving gastrostomy feeding. J Gastroenterol 2013, 48:1105-1110.
50. Sekizawa K., Matsui T., Nakagawa T., et al. ACE inhibitors and pneumonia. Lancet 1998, 352:1069.
51. Yamaya M., Yanai M., Ohrui T., et al. Antithrombotic therapy for prevention of pneumonia. J Am Geriatr Soc 2001, 49:687-688.
52. Caldeira D., Alarcão J., Vaz-Carneiro A., et al. Risk of pneumonia associated with use of angiotensin converting enzyme inhibitors and angiotensin receptor blockers: systematic review and meta-analysis. Br Med J 2012, 345:e4260.
53. Osawa A., Maeshima S., Tanahashi N. Efficacy of cilostazol in preventing aspiration pneumonia in acute cerebral infarction. J Stroke Cerebrovasc Dis 2013, 22:857-861.
54. Ikeda J.I., Kojima N., Saeki K., et al. Perindopril increases the swallowing reflex by inhibiting substance P degradation and tyrosine hydroxylase activation in a rat model of dysphagia. Eur J Pharmacol 2014, 746C:126-131.
55. Teramoto S., Yamamoto H., Yamaguchi Y., et al. Antiplatelet cilostazol, an inhibitor of type III phosphodiesterase, improves swallowing function in patients with a history of stroke. J Am Geriatr Soc 2008, 56:1153-1154.
56. Teramoto S., Yamamoto H., Yamaguchi Y., et al. ACE inhibitors prevent aspiration pneumonia in Asian, but not Caucasian, elderly patients with stroke. Eur Respir J 2007, 29:218-219.
57. Chang C.H., Lin J.W., Ruan S.Y., et al. Comparing individual angiotensin-converting enzyme inhibitors with losartan in the risk of hospitalization for pneumonia and related mortality: a nationwide cohort study. J Hypertens 2015, 33:634-643.
58. Teramoto S., Matsuse T., Oka T., et al. Investigation of effects of anesthesia and age on aspiration in mice through LacZ gene transfer by recombinant E1-deleted adenovirus vectors. Am J Respir Crit Care Med 1998, 158:1914-1919.
59. Ochoa-Gondar O., Vila-Corcoles A., Rodriguez-Blanco T., et al. Effectiveness of the 23-valent pneumococcal polysaccharide vaccine against community-acquired pneumonia in the general population aged ≥60 years: 3 years of follow-up in the CAPAMIS study. Clin Infect Dis 2014, 58:909-917.
60. Wiemken T.L., Carrico R.M., Klein S.L., et al. The effectiveness of the polysaccharide pneumococcal vaccine for the prevention of hospitalizations due to Streptococcus pneumoniae community-acquired pneumonia in the elderly differs between the sexes: results from the Community-Acquired Pneumonia Organization (CAPO) international cohort study. Vaccine 2014, 32:2198-2203.
61. Becker-Dreps S., Amaya E., Liu L., et al. Impact of a combined pediatric and adult pneumococcal immunization program on adult pneumonia incidence and mortality in Nicaragua. Vaccine 2015, 33:222-227.
62. Ansaldi F., Orsi A., Trucchi C., et al. Potential effect of PCV13 introduction on Emergency Department accesses for lower respiratory tract infections in elderly and at risk adults. Hum Vaccin Immunother 2015, 11:166-171.
63. Nakata S., Ishikawa H., Tachi H., et al. An elderly case of post-gastrectomy aspiration pneumonia following an influenza virus A infection. Nihon Ronen Igakkai Zasshi 2013, 50:661-666. [in Japanese].
64. Jefferson T., Di Pietrantonj C., Al-Ansary L.A., et al. Vaccines for preventing influenza in the elderly. Cochrane Database Syst Rev 2010, 2:CD004876.
65. Darvishian M., Gefenaite G., Turner R.M., et al. After adjusting for bias in meta-analysis seasonal influenza vaccine remains effective in community-dwelling elderly. J Clin Epidemiol 2014, 67:734-744.
66. Christenson B., Lundbergh P., Hedlund J., et al. Effects of a large-scale intervention with influenza and 23-valent pneumococcal vaccines in adults aged 65 years or older: a prospective study. Lancet 2001, 357:1008-1011.
67. Christenson B., Hedlund J., Lundbergh P., et al. Additive preventive effect of influenza and pneumococcal vaccines in elderly persons. Eur Respir J 2004, 23:363-368.